Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11119598 | 0.97 | CA2 (0.40) | CA2RECQLALDH1A1TSHRCYP3A4 | |
| SCHEMBL2027800 | 0.97 | CA2 (0.40) | CA2RECQLALDH1A1TSHRCYP3A4 | |
| Silver SCHEMBL2027796 | 0.97 | CA2 (0.40) | CA2RECQLALDH1A1TSHRCYP3A4 | |
| SCHEMBL9949603 | 0.97 | CA2 (0.40) | CA2RECQLALDH1A1TSHRCYP3A4 | |
| SCHEMBL51225 | 0.97 | CA2 (0.42) | CA2RECQLALDH1A1TSHRCYP3A4 | |
| SCHEMBL2425804 | 0.97 | CA2 (0.40) | CA2RECQLALDH1A1TSHRCYP3A4 | |
| Tetramethylammonium Ion SCHEMBL5525956 | 0.95 | CA2 (0.38) | CA2RECQLALDH1A1TSHRCYP3A4 | |
| Potassium Ion SCHEMBL466502 | 0.90 | CA2 (0.40) | CA2RECQLALDH1A1TSHRCYP3A4 | |
| SCHEMBL8903392 | 0.90 | CYP3A4 (0.34) | CA2TSHRCYP3A4 | |
| SCHEMBL1905631 | 0.88 | RECQL (0.39) | CA2RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010097643-A1 | FORMULATION BASED ON MICRONIZED ZEOLITE, GREEN TEA EXTRACT, AND GENISTEIN AS A THERAPEUTIC AGENT FOR REDUCTION OF BODY WEIGHT AND CELLULITE | NOVATECH ISTRAZIVANJE D.O.O. (HR) | 2010-09-02 | — | — | WO | claimed |
| US-7758684-B2 | Ink additive and ink using same | NISSIN CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-07-20 | — | — | US | claimed |
| WO-2010018418-A1 | FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS THERAPEUTIC AGENT PROVIDING HIGHLY BIOAVAILABLE SILICON | NOVATECH D.O.O. (HR) | 2010-02-18 | — | — | WO | claimed |
| US-20070283845-A1 | Ink additive and ink using same | NISSIN CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-12-13 | — | — | US | claimed |
| EP-0656965-B1 | LOW FUME FINISH FOR WET AIT-JET TEXTURING | DU PONT (US) | 1996-04-17 | — | — | EP | claimed |
| US-12528935-B2 | Latex composition for dip molding and dip-molded article | ZEON CORPORATION (JP) | 2026-01-20 | — | — | US | disclosed |
| US-12486384-B2 | Latex composition and dip-molded body | ZEON CORPORATION (JP) | 2025-12-02 | — | — | US | disclosed |
| US-12421375-B2 | Latex composition for dip molding and dip-molded article | ZEON CORPORATION (JP) | 2025-09-23 | — | — | US | disclosed |
| US-20250019502-A1 | PREPARING METHOD OF POLYMER POWDER FOR BINDER AND BINDER COMPOSITION | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2025-01-16 | — | — | US | disclosed |
| EP-3543261-B1 | SYNTHETIC POLYISOPRENE LATEX | ZEON CORP (JP) | 2023-09-06 | — | — | EP | disclosed |
| EP-3520750-B1 | METHOD OF MANUFACTURING PACKAGE STRUCTURE | ZEON CORP (JP) | 2023-05-24 | — | — | EP | disclosed |
| US-20230151193-A1 | LATEX COMPOSITION FOR DIP MOLDING AND DIP-MOLDED ARTICLE | ZEON CORPORATION (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20030065015-A1 | Novel quarternary ammonium compositions coupled with facilitating anions and their use in kits, as well as their use in preventing and treating certain conditions | BACANER MARVIN B (US) | 2003-04-03 | — | — | US | disclosed |
| US-6482811-B1 | Bretylium compositions and kits, and their use in preventing and treating cardio-vascular conditions | BACANER MARVIN B (US) | 2002-11-19 | — | — | US | disclosed |
| EP-1140054-A2 | BRETYLIUM COMPOSITIONS AND KITS, AND THEIR USE IN PREVENTING AND TREATING CARDIOVASCULAR CONDITIONS | Bacaner, Marvin B. (US) | 2001-10-10 | — | — | EP | disclosed |
| US-6261352-B1 | BETAINE, SULFO ESTER | THE PILOT INK CO., LTD. (JP) | 2001-07-17 | — | — | US | disclosed |
| WO-2000040232-A2 | BRETYLIUM COMPOSITIONS AND KITS, AND THEIR USE IN PREVENTING AND TREATING CARDIOVASCULAR CONDITIONS | BACANER MARVIN B (US) | 2000-07-13 | — | — | WO | disclosed |
| EP-0964036-A2 | Water-based ball-point pen ink composition | THE PILOT INK CO., LTD. (JP) | 1999-12-15 | — | — | EP | disclosed |
| US-4051299-A | ALKYLENE OXIDE ADDUCT EMULSIFIER, MONO- OR DI-ESTER OR OIL LUBRICANT | FIBER INDUSTRIES INC. (US) | 1977-09-27 | — | — | US | disclosed |
| US-3997450-A | ALKYLENE OXIDE FINISHES | FIBER INDUSTRIES, INC. (US) | 1976-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528935-B2 | Latex composition for dip molding and dip-molded article | GLO1, WDR1, PIM1 | CA2 4331/4885RECQL 3021/4885ALDH1A1 597/4885 |
| US-20030065015-A1 | Novel quarternary ammonium compositions coupled with facilitating anions and their use in kits, as well as their use in preventing and treating certain conditions | SLC10A1, ATP6V1B1, SLC7A1 | CA2 128/4885RECQL 748/4885ALDH1A1 3341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.